CHDI Management
| Name | Area | Department | Start Year | Stop Year | Advisor |
|---|---|---|---|---|---|
| Douglas Macdonald | Huntington's disease, biomarkers, gene therapy, gene silencing, GPCRs, mGluRs, Substance P, molecular pharmacology, TRK receptor, peptide synthesis, | Susan E. Leeman (grad student), R. Bruce Merrifield (research scientist) |